Serum prolactin and macroprolactin levels among outpatients with major depressive disorder following the administration of selective serotonin-reuptake inhibitors: A cross-sectional pilot study

PLoS ONE

Volumn 8, Issue 12, 2013, Pages

  Kim, Sollip ^a   Park, Young Min ^a  

^a Inje University College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ESCITALOPRAM; MACROPROLACTIN; PAROXETINE; PROLACTIN; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; UNCLASSIFIED DRUG; PROLACTIN, POLYMERIC;

ADULT; ARTICLE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; FEMALE; HUMAN; HUMAN CELL; HYPERPROLACTINEMIA; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; OUTPATIENT; PILOT STUDY; PREVALENCE; PROLACTIN BLOOD LEVEL; TREATMENT DURATION; AGED; BLOOD; DEPRESSIVE DISORDER, MAJOR; MIDDLE AGED;

ADULT; AGED; CROSS-SECTIONAL STUDIES; DEPRESSIVE DISORDER, MAJOR; FEMALE; HUMANS; MALE; MIDDLE AGED; PILOT PROJECTS; PROLACTIN; SEROTONIN UPTAKE INHIBITORS;

EID: 84891586578     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0082749     Document Type: Article

References (33)

1. Torre DL, Falorni A (2007) Pharmacological causes of hyperprolactinemia. Ther Clin. Risk Manag 3: 929-951.
2. Emiliano AB, Fudge JL (2004) From galactorrhea to osteopenia: rethinking serotonin-prolactin interactions. Neuropsychopharmacology 29: 833-846. doi:10.1038/sj.npp.1300412. PubMed: 14997175.
3. Cohen M, Davies P (1998) Drug therapy and hyperprolactinaemia. Adv Drug Reaction. Bull 190: 723-726.
4. Molitch ME (2008) Drugs and prolactin. Pituitary 11: 209-218. doi:10.1007/s11102-008-0106-6. PubMed: 18404390.
5. Spigset O, Mjorndal T (1997) The effect of fluvoxamine on serum prolactin and serum sodium concentrations: relation to platelet 5-HT2A receptor status. J Clin Psychopharmacol 17: 292-297. doi:10.1097/00004714-199708000-00009. PubMed: 9241009.
6. Urban RJ, Veldhuis JD (1991) A selective serotonin reuptake inhibitor, fluoxetine hydrochloride, modulates the pulsatile release of prolactin in postmenopausal women. Am J Obstet Gynecol 164: 147-152. doi:10.1016/0002- 9378(91)90645-8. PubMed: 1986602.
7. Laine K, Anttila M, Heinonen E, Helminen A, Huupponen R et al. (1997) Lack of adverse interactions between concomitantly administered selegiline and citalopram. Clin Neuropharmacol 20: 419-433. doi:10.1097/00002826-199710000- 00006. PubMed: 9331518.
8. Amsterdam JD, Garcia-España F, Goodman D, Hooper M, Hornig-Rohan M (1997) Breast enlargement during chronic antidepressant therapy. J Affect Disord 46: 151-156. doi:10.1016/S0165-0327(97)00086-4. PubMed: 9479619.
9. Salzman C, Jimerson D, Vasile R, Watsky E, Gerber J (1993) Response to SSRI antidepressants correlates with reduction in plasma HVA: pilot study. Biol Psychiatry 34: 569-571. doi:10.1016/0006-3223(93)90202-O. PubMed: 8274586.
10. Mück-Seler D, Pivac N, Sagud M, Jakovljević M, Mihaljević-Peles A (2002) The effects of paroxetine and tianeptine on peripheral biochemical markers in major depression. Prog Neuropsychopharmacol Biol Psychiatry 26: 1235-1243. doi:10.1016/S0278-5846(02)00259-2. PubMed: 12502009.
11. Sagud M, Pivac N, Mück-Seler D, Jakovljević M, Mihaljević-Peles A et al. (2002) Effects of sertraline treatment on plasma cortisol, prolactin and thyroid hormones in female depressed patients. Neuropsychobiology 45: 139-143. doi:10.1159/000054954. PubMed: 11979064.
12. Schlösser R, Wetzel H, Dörr H, Rossbach W, Hiemke C et al. (2000) Effects of subchronic paroxetine administration on night-time endocrinological profiles in healthy male volunteers. Psychoneuroendocrinology 25: 377-388. doi:10.1016/S0306-4530(99)00065-7. PubMed: 10725614.
13. Shlik J, Aluoja A, Vasar V, Vasar E, Podar T et al. (1997) Effects of citalopram treatment on behavioural, cardiovascular and neuroendocrine response to cholecystokinin tetrapeptide challenge in patients with panic disorder. J Psychiatry Neurosci 22: 332-340. PubMed: 9401314.
14. Papakostas GI, Miller KK, Petersen T, Sklarsky KG, Hilliker SE et al. (2006) Serum prolactin levels among outpatients with major depressive disorder during the acute phase of treatment with fluoxetine. J Clin Psychiatry 67: 952-957. doi:10.4088/JCP.v67n0612. PubMed: 16848655.
15. Shimatsu A, Hattori N (2012) Macroprolactinemia: diagnostic, clinical, and pathogenic significance. Clin Dev Immunol 2012: 167132
16. Hattori N, Ishihara T, Saiki Y, Shimatsu A (2010) Macroprolactinaemia in patients with hyperprolactinaemia: composition of macroprolactin and stability during long-term follow-up. Clin Endocrinol (Oxf) 73: 792-797. doi:10.1111/j.1365-2265.2010.03880.x. PubMed: 20874771.
17. Olukoga AO, Kane JW (1999) Macroprolactinaemia: validation and application of the polyethylene glycol precipitation test and clinical characterization of the condition. Clin Endocrinol (Oxf) 51: 119-126. doi:10.1046/j.1365-2265.1999.00757.x. PubMed: 10468974.
18. Coker F, Taylor D (2010) Antidepressant-induced hyperprolactinaemia: incidence, mechanisms and management. CNS Drugs 24: 563-574. doi:10.2165/11533140-000000000-00000. PubMed: 20527996.
19. Hattori N, Adachi T, Ishihara T, Shimatsu A (2012) The natural history of macroprolactinaemia. Eur J Endocrinol 166: 625-629. doi:10.1530/EJE-11-1007. PubMed: 22247016.
20. Leslie H, Courtney CH, Bell PM, Hadden DR, McCance DR et al. (2001) Laboratory and clinical experience in 55 patients with macroprolactinemia identified by a simple polyethylene glycol precipitation method. J Clin Endocrinol Metab 86: 2743-2746. doi:10.1210/jc.86.6.2743. PubMed: 11397880.
21. McKenna TJ (2009) Should macroprolactin be measured in all hyperprolactinaemic sera? Clin Endocrinol (Oxf) 71: 466-469. doi:10.1111/j.1365-2265.2009.03577.x. PubMed: 19320649.
22. Bjøro T, Mørkrid L, Wergeland R, Turter A, Kvistborg A et al. (1995) Frequency of hyperprolactinaemia due to large molecular weight prolactin (150-170 kD PRL). Scand J Clin Lab Invest 55: 139-147. doi:10.3109/00365519509089606. PubMed: 7667607.
23. Vallette-Kasic S, Morange-Ramos I, Selim A, Gunz G, Morange S et al. (2002) Macroprolactinemia revisited: a study on 106 patients. J Clin Endocrinol Metab 87: 581-588. doi:10.1210/jc.87.2.581. PubMed: 11836289.
24. Gibney J, Smith TP, McKenna TJ (2005) The impact on clinical practice of routine screening for macroprolactin. J Clin Endocrinol Metab 90: 3927-3932. doi:10.1210/jc.2004-2234. PubMed: 15811931.
25. Gibney J, Smith TP, McKenna TJ (2005) Clinical relevance of macroprolactin. Clin Endocrinol (Oxf) 62: 633-643. doi:10.1111/j.1365-2265.2005. 02243.x. PubMed: 15943822.
26. Hauache OM, Rocha AJ, Maia AC Jr., Maciel RM, Vieira JG (2002) Screening for macroprolactinaemia and pituitary imaging studies. Clin Endocrinol (Oxf) 57: 327-331. doi:10.1046/j.1365-2265.2002.01586.x. PubMed: 12201824.
27. Hattori N, Ishihara T, Saiki Y (2009) Macroprolactinaemia: prevalence and aetiologies in a large group of hospital workers. Clin Endocrinol (Oxf) 71: 702-708. doi:10.1111/j.1365-2265.2009.03570.x.
28. Kitaichi Y, Inoue T, Nakagawa S, Boku S, Kakuta A et al. (2010) Sertraline increases extracellular levels not only of serotonin, but also of dopamine in the nucleus accumbens and striatum of rats. Eur J Pharmacol 647: 90-96. doi:10.1016/j.ejphar.2010.08.026. PubMed: 20816814.
29. Richelson E (2003) Interactions of antidepressants with neurotransmitter transporters and receptors and their clinical relevance. J Clin Psychiatry 64 Suppl 13: 5-12. doi:10.4088/JCP.v64n0301. PubMed: 14552650.
30. Lee BH, Kang SG, Kim TW, Lee HJ, Yoon HK et al. (2012) Hyperprolactinemia induced by low-dosage amisulpride in Korean psychiatric patients. Psychiatry Clin Neurosci 66: 69-73. doi:10.1111/j.1440-1819.2011.02296.x. PubMed: 22250612.
31. Volavka J, Czobor P, Cooper TB, Sheitman B, Lindenmayer JP et al. (2004) Prolactin levels in schizophrenia and schizoaffective disorder patients treated with clozapine, olanzapine, risperidone, or haloperidol. J Clin Psychiatry 65: 57-61. doi:10.4088/JCP.v65n0109. PubMed: 14744169.
32. Karagianis JL, Baksh A (2003) High-dose olanzapine and prolactin levels. J Clin Psychiatry 64: 1192-1194. doi:10.4088/JCP.v64n1008. PubMed: 14658967.
33. Stevens JR, Kymissis PI, Baker AJ (2005) Elevated prolactin levels in male youths treated with risperidone and quetiapine. J Child Adolesc Psychopharmacol 15: 893-900. doi:10.1089/cap.2005.15.893. PubMed: 16379509.